CEP57 and prostate carcinoma: However, a study by Mang et al. (2015) suggests that high CEP57 expression in prostate cancer tumors is associated with mitotic impairment and, thereby, less aggressive tumor behavior and that the CEP57-induced microtubule stabilization does not affect AR nuclear translocation.